Neuberger Berman Group LLC Incyte Corp Transaction History

Neuberger Berman Group LLC

$123 Billion
Q3 2024

A detailed history of Neuberger Berman Group LLC transactions in Incyte Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 4,387 shares of INCY stock, worth $332,841. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,387

Previous 3,845 14.1%

Holding current value

$332,841

Previous $233,000 24.03%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$57.33 - $68.61 $31,072 - $37,186	542 Added 14.1%	4,387 $289,000
Q2 2024 Nov 14, 2024	SELL	$51.18 - $63.75 $89,206 - $111,116	-1,743 Reduced 31.19%	3,845 $233,000
Q2 2024 Aug 13, 2024	SELL	$51.18 - $63.75 $89,206 - $111,116	-1,743 Reduced 31.19%	3,845 $233,000
Q1 2024 Nov 14, 2024	BUY	$56.55 - $66.59 $32,572 - $38,355	576 Added 11.49%	5,588 $318,000
Q1 2024 May 13, 2024	BUY	$56.55 - $66.59 $316,001 - $372,104	5,588 New	5,588 $318,000
Q4 2023 Nov 14, 2024	BUY	$52.16 - $64.19 $60,870 - $74,909	1,167 Added 30.35%	5,012 $314,000
Q4 2023 Feb 09, 2024	BUY	$52.16 - $64.19 $68,225 - $83,960	1,308 Added 35.31%	5,012 $314,000
Q3 2023 Nov 14, 2023	SELL	$57.77 - $65.93 $172,327 - $196,669	-2,983 Reduced 44.61%	3,704 $213,000
Q2 2023 Aug 11, 2023	BUY	$60.95 - $75.51 $200,037 - $247,823	3,282 Added 96.39%	6,687 $416,000
Q1 2023 May 12, 2023	BUY	$70.23 - $86.01 $6,531 - $7,998	93 Added 2.81%	3,405 $246,000
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $6,852 - $8,579	102 Added 3.18%	3,312 $266,000
Q3 2022 Nov 15, 2022	BUY	$66.18 - $82.86 $212,437 - $265,980	3,210 New	3,210 $214,000
Q2 2020 Aug 13, 2020	SELL	$74.18 - $108.93 $29,375 - $43,136	-396 Reduced 0.29%	137,834 $14.3 Million
Q1 2020 May 14, 2020	SELL	$63.18 - $85.97 $2.99 Million - $4.07 Million	-47,386 Reduced 25.53%	138,230 $0
Q4 2019 Feb 12, 2020	SELL	$73.04 - $95.72 $380,392 - $498,509	-5,208 Reduced 2.73%	185,616 $16.2 Million
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $4,150 - $4,931	-57 Reduced 0.03%	190,824 $14.2 Million
Q2 2019 Aug 13, 2019	SELL	$73.52 - $88.7 $10.8 Million - $13.1 Million	-147,337 Reduced 43.56%	190,881 $16.2 Million
Q1 2019 May 13, 2019	SELL	$63.56 - $88.17 $205,489 - $285,053	-3,233 Reduced 0.95%	338,218 $29.1 Million
Q4 2018 Feb 12, 2019	SELL	$58.5 - $69.94 $3,217 - $3,846	-55 Reduced 0.02%	341,451 $21.7 Million
Q3 2018 Nov 13, 2018	SELL	$61.75 - $74.23 $114,361 - $137,473	-1,852 Reduced 0.54%	341,506 $23.6 Million
Q2 2018 Aug 13, 2018	BUY	$60.85 - $83.98 $13.1 Million - $18.1 Million	215,033 Added 167.57%	343,358 $23 Million
Q1 2018 May 08, 2018	BUY	$83.06 - $100.98 $10.4 Million - $12.7 Million	125,662 Added 4718.81%	128,325 $10.7 Million
Q4 2017 Feb 14, 2018	SELL	$93.56 - $116.6 $89,911 - $112,052	-961 Reduced 26.52%	2,663 $252,000
Q3 2017 Nov 15, 2017	BUY	$109.15 - $138.27 $395,559 - $501,090	3,624	3,624 $423,000

Others Institutions Holding INCY

# of Institutions

641

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.9B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Incyte Corp Transaction History